Eslami, G; Mousaviasl, S; Radmanesh, E; Jelvay, S; Bitaraf, S; Simmons, B; Wentzel, H; Hill, A; Sadeghi, A; Freeman, J; Salmanzadeh, S; Esmaeilian, H; Mobarak, M; Tabibi, R; Kashi, AHJ; Lotfi, Z; Talebzadeh, SM; Wickramatillake, A; Momtazan, M; Farsani, MH; Marjani, S; Mobarak, S
[Article-Full-text]
Objectives: Sofosbuvir and daclatasvir are direct-acting antivirals highly effective against hepatitis C virus. There
is some in silico and in vitro evidence that suggests these agents may also be effective against ...